Bile Acid Reference Standards: CRS, USP RS and Your Own

The UDCA monograph lists nine impurity letters. EDQM, the body that issues European Pharmacopoeia chemical reference substances, publishes four standards that cover the whole monograph. Four standards, nine letters. Everything in between has to be solved by the testing laboratory, and how that gap is solved decides whether a related-substances result means anything at all.

That arithmetic surprises people the first time they meet it. The assumption is usually that the list of letters is also a shopping list. It is not. A letter appears in a monograph because the drafting committee considered the impurity possible or likely; a reference standard appears in the catalogue when the monograph's own tests need one. Those are two different criteria, and they produce two different lists.

Three different things get called a "standard"

Most confusion in this area comes from one word doing three jobs.

Only the first of the three is a pharmacopoeial requirement. The other two exist because the first is impractical to use every day. The problems start when the boundary between them gets blurred, and the most common version of that problem is a laboratory treating a purchased impurity standard as though its purity figure were traceable when it is not.

Nine letters, four standards

Walk the current UDCA monograph test by test and the standard set is small and specific. Identification by infrared calls for ursodeoxycholic acid CRS. The impurity C test, which runs by thin-layer chromatography, calls for three: ursodeoxycholic acid CRS, lithocholic acid CRS as impurity C, and chenodeoxycholic acid CRS as impurity A. The related-substances liquid chromatography test calls for one further item, a system suitability standard that contains impurities A and H spiked into the active substance.

Two consequences follow, and both are practical.

The system suitability standard is not a substitute for individual standards. It exists to prove that the column separates impurity H from the main peak at a resolution of at least 1.5. That is a separation check, not a quantification tool. If you want to quantify impurity H, you need a characterised standard of it, and you will not find one in the pharmacopoeial catalogue.

Impurity F is the interesting case. It is 7-ketolithocholic acid, the molecule our A–I impurity reference and our note on why impurity F has no monograph of its own both cover. It sits inside a UDCA related-substances result as a relative retention, and it also exists as a commercial product in its own right. That means a buyer can source it as a substance, but the laboratory still has to qualify it as a standard before using it to assign a number.

What a working standard has to be able to prove

Establishing a working standard is not complicated, and it is routinely done badly. Three things have to hold.

1. Traceability. The working standard's identity and purity must be assigned by comparison with a pharmacopoeial standard, or with a material whose purity was assigned by an absolute method. A certificate that says "99.2% by HPLC" without stating how the response factor was assigned does not establish traceability.
2. Re-qualification. Working standards age. They take up moisture, they degrade, and their assigned content drifts. A working standard with no re-qualification interval written down is an assumption, not a standard.
3. Storage discipline. Pharmacopoeial standards for this family are supplied with refrigerated storage instructions, typically 2 to 8 °C, and they are issued in small quantities, often tens of milligrams. How a laboratory handles 90 mg of CRS says a lot about how it handles everything else.

Why the purity basis matters more than the purity value

This is the part I would push hardest on with any laboratory, and it is the part most often skipped.

Suppose you buy an impurity standard stated as 97% pure by HPLC area. You use it to build your calibration curve, and you report an impurity at 0.08% against a 0.10% limit. Now ask what that 97% means. If it was assigned by high-performance liquid chromatography with a UV detector and a relative response assumption, then the 3% is unaccounted for and the actual content of the substance may be anywhere. If it was assigned by quantitative nuclear magnetic resonance, the mass fraction is measured directly against an internal standard and the number is a mass fraction rather than an area fraction.

For limits in the region of 0.10%, that difference is not academic. It is the same order of magnitude as the limit itself. A laboratory quantifying bile acid impurities against area-percent standards is reporting numbers with a systematic bias, and the bias is invisible on the certificate. The reason bile acids make this worse than average is the same reason the monograph runs its related-substances test on a refractive index detector: these molecules have no useful ultraviolet chromophore, so every UV-based purity claim on a bile acid standard deserves a second question.

When you are assessing a supplier, this is also a useful question to hand to their quality department. Ask how the impurity standards used in their related-substances method were assigned. The answer tells you whether the numbers on the certificate were produced by a system that could produce a wrong number without noticing.

Europe and the United States do not share standards

A programme working to the European Pharmacopoeia buys EDQM standards. A programme working to the United States Pharmacopeia buys USP reference standards for the same tests. The two are not interchangeable, and a certificate that reports an EP test result while naming a USP standard is worth a query.

There is one more distinction worth keeping straight in the supplement-facing part of this business, because it gets muddled constantly. USP reference standards are materials for use in pharmacopoeial tests. The USP Verified programme, which puts a mark on finished dietary supplement products, is a separate certification activity with its own scope. A statement that a raw material is "USP verified" is not a statement that a USP reference standard was used, and it is not a statement of monograph conformance either.

Where this shows up in a supplier conversation

You will not normally see any of this on a certificate of analysis. What you will see is a related-substances block with numbers on it, and the standard set is invisible behind those numbers. That is why the useful questions are structural rather than numerical.

• Which pharmacopoeial standards does your related-substances method use, by name?
• For impurities with no pharmacopoeial standard, how was the standard characterised?
• What is the re-qualification interval on your working standards?
• Are the reported percentages area-normalised or mass-based?

A supplier who can answer these has a functioning analytical operation. A supplier who cannot is relying on someone else's certificate, and the difference will show up the first time a result is disputed.

Frequently asked questions

Are there reference standards for all UDCA impurities?

No. The European Pharmacopoeia catalogue covers a small number of them: ursodeoxycholic acid CRS, lithocholic acid CRS as impurity C, chenodeoxycholic acid CRS as impurity A, and a system suitability standard containing impurities A and H. The remaining letters have no pharmacopoeial standard.

What is the difference between a CRS and a working standard?

A CRS is issued by the pharmacopoeia for use in the tests the monograph prescribes. A working standard is your own material, qualified against a CRS or by an absolute method, used for routine work. Only the CRS carries pharmacopoeial status; the working standard carries traceability to it.

How should a CRS be stored?

Pharmacopoeial standards in this family are supplied with refrigerated storage instructions, typically 2 to 8 °C. Follow the storage condition printed on the leaflet for the specific standard rather than a general rule.

Can I use a commercial impurity standard instead?

Yes, for impurities where no pharmacopoeial standard exists, which is most of the list. Check how the assigned purity was determined. A mass-fraction assignment by quantitative NMR is a different quality of number from an HPLC area percentage.

Is the system suitability standard an impurity standard?

No. It contains impurities A and H at levels chosen to demonstrate chromatographic resolution of at least 1.5 between impurity H and the main peak. It tests the method's separating power, not the quantity of impurity present.

Do I need to buy reference standards at all as a buyer?

Not usually. The supplier's laboratory does. What you need is enough visibility into how their standards were qualified to judge whether the numbers on the certificate are trustworthy.

The question that reveals the analytical operation

Ask how the standards behind the impurity numbers were assigned, and listen for the word "NMR". A laboratory that quantifies by mass fraction knows exactly why it does so. A laboratory that has never been asked the question has been reporting numbers it cannot fully defend, and it may not know that yet.

The primary sources behind this piece are the EDQM reference standards catalogue, the European Pharmacopoeia, and the USP reference standards programme. Catalogue contents change with each monograph revision, so confirm the current list before planning a laboratory setup.

The limits that these standards are used to control are set out in how the related-substances limits add up. What we ship against is on the ursodeoxycholic acid page, and specification questions for a specific quantity can be raised through a quotation request.

This article describes analytical standards and method attribution for quality, regulatory and procurement professionals. It states no therapeutic use, dose or indication for any substance, and no order quantity or lead time. Confirm all standard references against the current pharmacopoeial catalogue.